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Abstract
Glial cells, the resident immune cells of the brain, are important for brain health; they perform
critical protective functions following brain injury, during nervous system development, and to
support general neuronal activity. Following brain injury, glia quickly respond by cleaning up
neuronal and synaptic debris. In addition to their role as the cleaning cell of the brain, recent
research has shown that during development, glia also shape and fine-tune neural connections by
eliminating weak synapses fated for removal. However, whether glial cells also continue to remodel
synaptic architecture in the adult brain is unclear. Moreover, synaptic loss is an early hallmark of
Alzheimer’s disease (AD), but whether glial cells play a role in this pathophysiology remains
mysterious. In this study, we investigate the role of glial cells in AD-related synaptic loss using a
Drosophila melanogaster model of AD. Specifically, we will explore the role of the glial engulfment
receptor Draper, which is essential for glial clearance of neuronal debris after injury, and evaluate
its effect on synaptic loss in the AD fly model. For these studies, we will use immunohistochemistry
and western blotting techniques, as well as the power of Drosophila genetics. Through this project,
the effects of amyloid beta on synaptic molecule expression are assessed and the contribution of
the glial engulfment receptor Draper upon amyloid-beta induced synaptic changes are identified.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative disease, which is implicated by
hallmark aggregations of extracellular amyloid beta protein. Mutations in the amyloid precursor
protein (APP), causing a truncated version of the protein have been identified as a risk factor for
Alzheimer’s disease (Goate et al. 1991; Citron et al. 1992). However, attention is also shifting to
the immune cells of the brain called microglia. As the resident immune cells of the brain, they are
actively surveying the brain parenchyma for injury (Nimmerjahn et al. 2005). Upon injury, they
quickly respond, by changing their morphology and protein expression to engulf cellular and
synaptic debris through active phagocytosis (Ivacko et al. 1996). In addition, microglia are critical
for proper brain development as they shape synaptic connections during development. It has been
shown that developing mice deficient for one essential microglial engulfment receptor displayed
unrefined synaptic connectivity due to deficits in synaptic pruning (Paolicelli et al. 2011; Zhan et al.
2014).
In Drosophila, the glial engulfment receptor Draper has been shown to be essential in glial
engulfment of neuronal debris following injury (MacDonald et al. 2006). Upon axon injury, glial
cells recruit their membranes at the site of injury and upregulate Draper. When Draper is knocked
down or glial phagocytic activity is inhibited, axon fragments persist and are not cleared (Doherty
et al. 2009). While Draper is specific to Drosophila, it is highly conserved and its mammalian
homolog MEGF10 shows similar function in glial engulfment in mammals (Chung et al. 2013). This
positions Draper as an essential and specific glial receptor for the interaction between glial cells
and damaged/dying neurons and allows us to use the powerful Drosophila model to investigate
conserved pathways.
In improving our understanding of Alzheimer’s disease, recent data suggests that amyloid
beta aggregation is not the very first or critical molecular symptom of Alzheimer’s disease (Scheff
and Price 2003). In mice, synaptic loss and dysfunction has been observed before any sign of
hallmark aggregation (Yoshiyama et al. 2007), however whether glial cells are involved in this
process is not clear. In addition, defects in glial cells have been shown to accumulate in the aging
brain potentially leading to disease (Hanisch and Kettenmann 2007; 2010). We aim to validate a
Drosophila model of Alzheimer’s Disease and create a timeline of when synaptic loss occurs in
relation to neurodegeneration. Using this timeline, we will then be able to examine the role of glia
in this process by investigating whether synaptic loss still occurs in the AD fly model when Draper
is knocked out. By investigating the very initial pathophysiology observed in Alzheimer’s Disease
and its associated signals, we hope to shed light on a potentially powerful mechanism to halt
Alzheimer’s Disease before it leads to progressive neurodegeneration and cognitive decline.

Methods
Fly Lines
w+/-; elav-Gal4/ UAS-Aβarc; +
w+/-; elav-Gal4/ w118; +
w+/-; elav-Gal4/BRP-SNAP; UAS-Aβarc
w+/-; elav-Gal4/ BRP-SNAP; +
w+/-; elav-Gal4/ BRP-SNAP; Drpr Δ5 rec 9/UAS-Aβarc Drpr Δ5 rec 9
Crosses were set up and maintained at 25o C. Flies were collected every 2 days (M, W, F) and
incubated at 30o C.
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Adult Fly Brain Fixation
Fix Solution 1- 1x PBS, 0.01% Triton-X, 4% Paraformaldehyde
Wash Solution 1- 1x PBS, 0.01% Triton X
Fix Solution 2- 1x PBS, 0.1% Triton-X, 4% Paraformaldehyde
Wash Solution 2- 1x PBS, 0.1% Triton X
Adult flies from chosen groups were anesthetized and heads removed. Heads were fixed in Fix
Solution 1 for 20 minutes with rocking. Heads were washed in wash solution 1 3 x 2 minutes.
Brains were dissected in wash solution 1 in a standard dissection plate. Newly dissected brains
were transferred to new tubes with wash solution 1. Wash solution 1 was pipetted out and replaced
with Fix Solution 2. Brains were fixed for 20 minutes at room temperature with rocking. Brains
were washed 3 x 2 minutes in wash solution 2.
Antibody Staining
Primary antibody master mixes were prepared at the following concentrations, diluting the antibody
in wash solution 2:
Mouse Anti-Draper 1:400; Guinea Pig Anti- Draper 1:400; Mouse Anti-Aβ 1:2000; Mouse AntiBruchpilot 1:50.
Secondary antibody master mixes were prepared at the following concentration, diluting the
antibody in wash solution 2:
Mouse 488 1:400; Guinea Pig 546 1:400 (Jackson Immuno).
Brains were incubated in primary antibody with shaking at 4oC overnight. Brains were washed 4 x
30 minutes in wash solution 2. Brains were then incubated in secondary antibody for 2 hours at
room temperature with shaking and then washed 4 x 30 minutes in wash solution 2.
BRP-SNAP Staining
SNAP Tag mix was prepared at a concentration of 1 µM in 1x PBS with 0.3% Triton X. Brains were
permeabilized for 1 x 10 min in 1x PBS with 0.3% Triton X for 10 min prior to staining. Brains were
stained for 15 minutes at room temperature in a glass dissection dish with rocking. Brains were
washed 1 x 5 min in 1x PBS & 0.3% Triton X and 1 x 5 min in 1x PBS.
Mounting
Brains were transferred to the glass well of a dissection dish and the wash solution was carefully
removed with a pipette. A drop of Vectashield (Vector Labs) was then immediately dispensed onto
the brains. Brains were incubated for 30 minutes at 4oC or overnight if desired. Slide preparation
required placing a strip of clear tape onto a clean microscope slide. A template was used to trace
and cut 4 wells into the tape. Brains were carefully transferred from the dissection dish to their
appropriate well on the microscope slide. Excess Vectashield was carefully removed and brains
were aligned and oriented with antennal lobes facing up. Small drops of Vectashield were added
once all brains were oriented and a coverslip was gently dropped onto the wells. The coverslip was
sealed around the border with a layer of CoverGrip (Biotium).
Confocal Microscopy and Quantification
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Images were taken on a Zeiss LSM 700 confocal microscope using a 40X oil immersion lens. For
Draper staining, 11 slices through the Z plane were taken per brain at an interval of 1 µm. For
Bruchpilot staining, 35 slices were taken through the Z plane at an interval of 0.5 µm.
Quantification was completed using the Volocity software (Perkin & Elmer). For Draper staining, the
5 slices, which depicted the same anatomical region in each sample, were quantified. Two standard
circles were used to measure regions within the cortex above the antennal lobes. A threshold for
background fluorescence was set in addition to a restriction of voxels 0.2 um in size or greater. For
Bruchpilot staining, the 20 slices, which depicted the same anatomical region, were quantified. The
antennal lobes were traced out, cropped and quantified. A threshold for background fluorescence
was set in addition to a restriction of voxels 0.2 um in size or greater. Data was analyzed and
graphed in GraphPad Prism 6.
Western Blot Protocol
Whole heads were pulled and collected in 1X loading buffer (10 heads per 30 uL of 1x loading
buffer). Samples were homogenized using a pestle and centrifuged for 10 minutes at 4 oC.
Supernatant was collected and boiled for 10 minutes at 95oC and frozen at -80oC.
10x running buffer was diluted to 1x and chilled at 4oc prior to use. 12 uL of sample was loaded
into each well of a 10% Tris-HCl gel. 1.5 µL of protein ladder was loaded into edge lanes. Gel was
run at a constant 125V for 2 hours.
The wet transfer sandwich was prepared after the fiber pads, filter paper, and nitrocellulose
membrane were soaked in transfer buffer. Gel sandwich was placed back in gel and ran at 100V for
90 minutes.
Membrane was soaked in methanol and then blocked with SEA Block (Calbiochem) for 30 min.
Membrane was incubated overnight at 4oC with primary antibodies of the following concentrations:
Rabbit Anti-Draper 1:2000 and Sheep Anti-Tubulin 1:4000. Membrane was washed 3 x 10 min in
1xPBS-Tween. Secondary antibodies (Rabbit 790 1:2000 & Sheep 680 1:2000) were prepared in
1X PBS and applied to membrane for 2 hours at room temperature. Membrane was washed 2x5
minutes in 1xPBS-Tween and 2x 5 minutes in 1xPBS. Membrane was visualized on Li-Cor Odyssey
Imager.

Results
Note:
Control: w+/-; elav-Gal4/ w118;
Experimental: w+/-; elav-Gal4/ UAS-Aarc; +

Flies show progressive Aβ accumulation in cortex
In verification of our Drosophila model, brains were stained for Amyloid Beta which can be seen in
cyan within the cortex (Figure 1). Control (w +/-; elav-Gal4/w118) flies showed no Amyloid Beta
plaques. In addition, Amyloid Beta displays an increase in aggregation from the 1-3 D time point to
the the later time point of 12-14 Days. Amyloid Beta was not quantified. Taken together, these
initial results allow for a confirmation that our model system displays characteristic Alzheimer’s
disease pathology.
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Figure 1: Flies show progressive Aβ aggregation in cortex. A) Elav-Gal4 UAS-Aarc 1-3 Days
immunostained for Draper (magenta) and Amyloid Beta (cyan). B) Elav-Gal4 UAS-Aarc 12-14
Days immunostained for Draper (magenta) and Amyloid Beta (cyan).

Draper fluorescence is increased in young AB flies
Whole brains were stained for Draper (Figure 2) and the Draper fluorescence within the cortex was
quantified (Figure 3). The Draper fluorescence was elevated, although not significantly, in flies
expressing the Aβ-arc mutation. This data suggests that Draper’s engulfment activity within glial
cells is possibly elevated as well.
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Figure 2: Draper fluorescence is increased in young A flies. A) Elav-Gal4 x Wt 1-3 Days
after eclosion immunostained for Draper (green). B) Elav-Gal4 UAS-Aβarc 1-3 Day flies
immunostained for Draper. n= 6-15. C) Fluorescence within two standard circle regions within the
cortex was quantified using Volocity software. n= 6-15.

Synaptic fluorescence and density is decreased in young A flies
To further delineate glial activity, synaptic levels were assessed via immunofluroescent staining
targeting the synaptic protein Bruchpilot. Control flies displayed elevated fluorescence, although
not statistically significant, suggesting that Aβ-arc expressing flies have a deficit in synaptic
density.

Figure 3: Synaptic density is decreased in young A flies. A) Elav-Gal4 x Wt anntenal lobe
aged 1-4 days stained for Bruchpilot synaptic protein. B) Elav-Gal4 UAS-Aβarc aged 1-4 Days
stained for Bruchpilot synaptic protein. n= 8-13. C) Fluorescence within antennal lobes was
quantified using Volocity software. n= 8-13.

Draper protein is similary expressed in whole brains of WT and AD flies
In order to more quantitatively assess Draper levels within the control and experimental groups, a
Western Blot was performed to directly analyze protein levels. When quantfied and normalized
against the corresponding total protein gel, Draper protein levels were similar amongst both control
and experimental groups. This suggests that minimal differences exist in Draper protein expression
between groups in whole brain lysates.
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Figure 4: Western Blot of Draper and Tubulin. A) From left: Ladder, Lanes 1 & 2: Experimental
1-3 Days, Lanes 3 & 4: Control 1-3 Days. Green band refers to Draper. Red band refers to Tubulin.
B) Total protein gel served as loading/normalization control. C) Draper bands were quantified and
normalized against corresponding lanes in total protein gel.

Draper deficiency does not rescue synapses
To ultimately evaluate whether Draper exerts some role on synaptic loss in the earliest stages of
Alzheimer’s Disease, Draper null Aarc flies were examined for Bruchpilot fluorescence. Draper null
flies in an Aarc background showed no rescue or increase in synapses in comparison to Aβarc
flies.
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Figure 5: Draper is not essential for AD synaptic loss. w +/-; elav-Gal4/BRP-SNAP; UASAβarc in left column; w +/-; elav-Gal4/ BRP-SNAP; Draper null/UAS-Aβarc Draper null in right
column. Synapses were stained using a molecular probe against an endogenous SNAP-Tag
attached to Bruchpilot. n= 11-16.

Discussion
Glial cells are a multi-faceted cell type playing essential roles in development, injury, and
maintenance. Their significant contribution to the brain microenvironment makes them a prime
candidate to investigate what effect they may have on early Alzheimer’s disease (AD), which is
best characterized by synaptic loss that occurs before the onset of symptoms like memory loss. As
glial cells are capable of pruning and engulfing synapses during development, this study aimed to
investigate how glial cells may be involved in synaptic loss in the context of Alzheimer’s disease.
More specifically, the highly conserved glial engulfment receptor Draper has previously been shown
to be crucial for glial engulfment activity following neuronal injury (MacDonald et al. 2006; Doherty
et al. 2009). Therefore, we hypothesized that Draper may also be upregulated and involved in AD
related synaptic loss.
For this study, we used a Drosophila model of Alzheimer’s disease, in which human Aß is
expressed pan-neuronally in the fly brain. In humans and mouse models of Alzheimer’s disease,
this protein forms aggregates and leads to destruction of neurons. More specifically, the expressed
Aß protein in our fly model contained the arctic mutation, which is known to cause severe protein
aggregation in human disease (Nilsberth et al. 2001). In our model, we observed the formation of
Aß-aggregates in the fly brain shortly after eclosion, and they increased in size and number with
age. In addition, we observed motor deficits in the Aß-expressing flies and a reduced lifespan
compared to age-matched controls. The advantages of this model system in Drosophila are the
ability to selectively express human Amyloid Beta in all neurons by utilizing the Elav-Gal4 UAS
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system. The limitations are that the current model does not allow for adult specific Aβ expression.
Instead, Aβ is expressed throughout development thereby quickly forming plaques after eclosion.
This is in stark contrast to human Alzheimer’s Disease pathology which requires decades for Aβ
plaques to form.
By utilizing immunohistochemistry techniques, Draper and the presynaptic protein
Bruchpilot were visualized and quantified in both experimental Aß-expressing and age matched
non-Aß expressing control groups. Bruchpilot staining revealed that synapses were decreased in
young (1-4 Days) Aβ flies (Figure 3), while Draper staining in young (1-3 day old) Aβ flies showed
an upregulation of Draper in the olfactory antennal lobe region of the adult fly brain (Figure 2).
These studies suggested that Draper may play a role in glial cell mediated synaptic loss in AD.
To further investigate whether Draper is involved in early synapse loss in AD, an Aßexpressing fly line in a Draper null mutation background was created. This allowed us to explore
whether the removal of Draper would result in an increase or rescue of synapses. Staining with a
fluorescent molecular probe against an endogenous SNAP-Tag attached to Bruchpilot allowed for
more specific and thorough staining in a control group (w+/-; elav-Gal4/BRP-SNAP; UAS-Aßarc)
and experimental Draper null group (w+/-; elav-Gal4/ BRP-SNAP; Draper null/UAS-Aßarc Draper
null). This study revealed that Draper removal conferred no increase or rescue of synapses (Figure
5). This preliminary data suggests that Draper is not essential in inducing synaptic loss in AD.
However, this does not eliminate the possibility that glial cells contribute to synaptic loss.
Alternative glial engulfment pathways such as the Crk/Mbc/dCed-12 may be implicated in synaptic
loss. The Crk/Mbc/dCed-12 pathway acts in a semi non-redundant fashion downstream of Draper
to actively phagocytose and uptake cellular debris (Ziegenfuss et al. 2012). While Draper is
required for initial glial activation in response to injury, this study suggests that it is not the key
player for AD-related synaptic loss. Other mediators in the glial engulfment pathway downstream
of Draper, such as the Crk/Mbc/dCed-12 pathway, should be investigated in future research.
Although Draper was seen to be upregulated in young Aβ flies but does not rescue synaptic
loss when knocked down, it may be upregulated for a myriad of other biological reasons. Glial cells
are known to engulf Aβ plaques and prune synapses during development (Bolmont et al. 2008;
Paolicelli et al. 2011; Chung et al. 2013) and this could be the reasons Draper upregulation was
observed in our Drosophila AD model. Future work should include refining the AD model in
Drosophila in order to better mimic the pathophysiology of AD. For example, in our experimental
group, Aß was expressed throughout development and plaques form a few days after eclosion. In
order to create a more realistic AD model, Aβ could be expressed strictly in adult flies without
perturbing development. This may model the human age-related disease more closely. This may be
accomplished through the use of a weaker neuronal driver than Elav-Gal4, or through genetically
inhibiting Aß expression during the fly’s development.
In conclusion, this study provides a preliminary depiction of the role of Draper in glial
mediated synaptic loss in the context of AD. Further research would include repeating these
experiments and investigating other engulfment pathways which may be implicated in the earliest
symptoms of AD.
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